High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.6M
$1,613,381
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| TARS |
Tarsus Pharmaceuticals, Inc.
|
COO
10b5-1 Sell
|
2026-03-20 | $199,516 | S | Form 4 |
| TARS |
Tarsus Pharmaceuticals, Inc.
|
COO
Sell to Cover
|
2026-03-19 | $307,463 | S | Form 4 |
| TARS |
Tarsus Pharmaceuticals, Inc.
|
COO
Sell to Cover
|
2026-03-18 | $248,043 | S | Form 4 |
| TARS |
Tarsus Pharmaceuticals, Inc.
|
COO
Sell to Cover
|
2026-03-17 | $216,938 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Neervannan Seshadri
• COO
10b5-1 SellΔOwn -10.6%
2026-03-04
$641,421
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
COO
10b5-1 SellΔOwn -10.6%
|
2026-03-04 | $641,421 | S | Form 4 |